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ABSTRACT
Background: Emerging resistance to antimicrobial drugs increases morbidity and
mortality by hampering the provision of effective chemotherapy, and makes treatment
more costly. The emergence of resistance to antimicrobial agents is a global public
health problem, especially in pathogens causing nosocomial infections.
Objectives: To determine the carriage of E. coli from wounds and urine in catheterised 
inpatients at Thika District Hospital (TDH) and to determine antimicrobial resistance 
patterns to β-lactams, aminoglycosides and (fluoro) quinolones.
Design: A cross-sectional study.
Setting: Thika District Hospital among hospitalised patients.
Subjects: A total of 450 specimens were collected and forty two (42) Escherichia coli 
isolated. Pus swabs were collected from wounds and urine was collected aseptically
from the inpatients with catheters. Escherichia coli were identified by culture methods
and biochemical tests. Antimicrobial susceptibility testing was performed by Kirby-
Bauer disc diffusion method and interpreted according to Clinical Laboratory Standards
Institute recommendations.
Results: Susceptibility results in aminoglycosides were, resistance for amikacin,
gentamicin and kanamycin was 20%, 39% and 51% respectively. Resistance in penicillin
was ampicillin 85% and piperacillin 83%. Resistance for sulfamethoxazole was 83%,
tetracycline 66 %, nalidixic acid 44 % and chloramphenicol 39%. In amoxicillin/clavulanic
acid, resistance was 68%. Cephalosporins’ resistance was ceftazidime 22 %, cefotaxime
56 %. Resistance for imipenem and tazobactam was 7% and 12 % respectively.
Conclusion: Due to observations on resistance to antimicrobial agents commonly used
in Thika District Hospital, this shows that there is need to revise antimicrobial policy
in this region in the treatment of E. coli infections.
INTRODUCTION
Escherichia coli (E.coli) are facultative anaerobe
Gram-negative rods, are motile, and some posses’
capsules while others are non-capsulated (1). It
is normally found in the gut of both man and
animals. However it also colonises the lower end
of urethra and vagina. Escherichia coli cause urinary
tract infections, neonatal meningitis, diarrhoea and
septicaemia (1). It is the leading pathogen causing
urinary tract infections (2). Escherichia coli is also
among the most common pathogens that cause
blood stream infections (3), wounds, otitis media
and other complications in humans (4).
Resistance to antimicrobials in E. coli has been
reported worldwide (5). There is increasing rates of
resistance among E. coli which is a growing concern
in both developed and developing countries (6).
Treatment options for E. coli strains include β-lactam
antimicrobials, aminoglycosides and (fluoro)-
quinolones. In most cases combined therapy
comprising, a β-lactam antimicrobials and a (fluoro)
quinolone or an aminoglycoside is prescribed
for serious infections. Cephalosporins alone as a
monotherapy or as a β-lactam/ β-lactamase inhibitor
such as amoxicillin-clavulanic acid combinations
may be effective against E. coli infections.
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MATERIALS AND METHODS
Study site: The study was conducted at Thika District
Hospital, Kiambu County, Kenya.
Study population: The study population included both 
adults and children who gave consent to participate
in this study. For children, consent was given by
their parents or guardians. All study participants
had been admitted in the ward for at least 48 hours.
They were all in-patients with wounds, burns
wounds and those with indwelling urine catheters.
Information sheets explaining the purpose of the
study and the procedures involved were given to the
patients/guardians. Patients/guardians who agreed
to participate in the study were given the consent
form to sign.
Design of the study: A cross-sectional study design
was used.
Sampling: Sterile cotton swabs were used to aseptically
collect specimens from fresh burn sites and surgical
wounds. The swab was rolled gently on the surface
area of the wound for about five seconds. The
cotton swab was inserted directly into sterile bottle
containing Stuart transport media. The handle of the
swab was snapped off, with cotton tip remaining
in the transport media. The bottle was sealed and
then labeled with the patient’s study number, ward
and date. Urine specimens were collected in sterile
universal bottles from patients with catheters. The
specimens were labeled with the study number,
ward and date. These specimens were delivered
immediately to the microbiology department in the
laboratory for processing.
Laboratory procedures: Processing of urine and pus
swabs specimens. Swabs collected from wounds
and urine from catheterised patients was processed
according to standard operating procedures. Swab
specimens were first inoculated on blood agar
media and then in MacConkey media for lactose
fermentation determination. Smears were then
prepared and a Gram stain performed. Culture
plates were incubated aerobically at 37 °C for 18-24
hours. The identity of the isolates was confirmed by
standard laboratory methods which included colony
morphology, lactose fermentation, gram staining,
oxidase, triple sugar iron, motility, and indole and
citrate utilisation.
Antibiotic Susceptibility Testing :  Antibiotic 
susceptibility test was done using Kirby-Bauer Disc 
diffusion method. At least four to five isolated colonies 
of the same morphologic type was selected from an
overnight agar plate of a pure culture and emulsified
in 10 ml sterile normal saline (0.85% sodium chloride)
in sterile glass tubes. Susceptibilities were tested
to antimicrobials commonly used for treatment of
infections caused by E. coli including aminoglycosides
thus gentamycin (10μg), amikacin (30μg), and
kanamycin (30μg). Beta-lactams included piperacillin
(100μg), amoxicillin/clavulanic acid (20/10 μg),
piperacillin/tazobactam (100/10 μg), cefotaxime
(30μg), ceftazidime (30μg) and imipenem (10μg).
Fluoro-quinolones included nalidixic acid (30μg),
ciprofloxacin (5μg) and ofloxacin (5 μg). Other agents
were trimethoprim/ sulfamethoxazole (25μg) and
tetracycline (30μg) (all from Oxoid, Basingstoke,
UK).
 Quality control organisms used to test for disc
potency and media quality were ATCC E. coli 25922.
The plates were incubated at 37oC for 18-24 hours.
Susceptibility results were interpreted according to
the Clinical Laboratory Standards Institute (CLSI)
2011.
 Data entry and analysis were performed using
Ms excel and STATA tool respectively. Categorical
data were tested using chi-square test. P-values of <
0.05 were considered statistically significant.
Ethical clearance for the study was obtained from
Kenya Medical Research Institute (KEMRI) Scientific
Steering Committee and Ethical Review Committee
(ERC No. 2081). Approval was also obtained from
Medical superintendent, Thika District Hospital
and informed consent from the patients or their
guardians.
June 2014 East african MEdical Journal    187
RESULTS
Figure 1
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 Resistance profile of E. coli in varying age groupss
A comparison of the resistance profiles of strains obtained from two age groups was done, that is, those between 
0 and 59 years and 60 years and above. It was noted that generally, there were no significant differences in
resistance to combinations of antimicrobial agents between the two groups (P: 0.9115).
Figure 2
Comparison of resistance patterns of E. coli among a cephalosporin, combined resistance to gentamicin and 
ciprofloxacin, and sulfamethoxazole
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Comparison of resistance patterns of . coli among a cephalosporin, combined resistance to gentamicin and 
ciprofloxacin, and sulfamethoxazole
Resistance patterns were compared among strains showing resistance to at least a cephalosporin such 
as cefotaxime and those with combined resistance to ciprofloxacin, gentamicin and those resistant to 
sulfamethoxazole.  Those with combined resistance to ciprofloxacin and gentamicin were resistant to more 
combinations of antimicrobials than those susceptible to these antimicrobials (P: 0.0066).
Figure 3
Resistance patterns of E. coli from different sources of specimen
Investigations were done on whether there were significant differences in resistance patterns of strains 
depending on the source of specimen. A comparison of resistance of strains obtained from surgical sites 
and those from burns, bedsores and urine was done and it was found that isolates from non-surgical sites 
were slightly more resistant than those from surgical specimens ( P: 0.0261).
Resistance p tterns were compared among strains showing resistance to at least a cephal sporin such
as cefotaxi e and those with co bined resistance to ciprofloxacin, gentamicin and those resistant to
sulfamethoxazole. Those with combined resistance to ciprofloxacin and gentamicin were resistant to more
combinations of antimicrobials than those susceptible to these antimicrobials (P: 0.0066).
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Comparison of resistance patterns of E. coli between males and females
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Figure 4
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Analysis to compare resistance patterns between E. coli strains obtained from males and females revealed 
no differences between the two populations (P: 0.8575). 
DISCUSSION
Escherichia coli have widely been associated with 
various clinical hospital acquired infections (7).  The 
results of antimicrobial resistance pattern give serious 
cause for concern because the predominant bacterial 
isolates were highly resistant to the commonly 
available antimicrobial agents in Kenya. Majority 
of strains from all specimen types were found to 
be multi-drug resistant (MDR). Similar results have 
been published before (8).  These findings show that 
in general, isolates from burns and surgical wounds 
are the second most resistant strains after those from 
urinary tracts.
 Although majority of strains were susceptible to 
carbapenems, some E. coli strains that were resistant 
to imipenem were identified. Carbapenems however 
remain the drugs of choice against the strains 
investigated as reported in a related study (9).
 This study reveals that a significant proportion 
of isolates from wounds and burns are highly multi-
drug resistance. The burn patients are particularly 
predisposed to different infections which are linked 
to impaired resistance from disruption of the skin’s 
mechanical integrity and generalized immune 
suppression (10). In these patients, the skin barrier is 
replaced by a protein rich, avascular environment that 
provides a favorable niche for microbial colonization 
and proliferation (11). It is also common for patients 
with wounds and burns to use topical microbial 
applications especially those containing heavy 
metals such as silver and those with neomycin and 
tetracycline. Such practices may promote emergence 
of highly resistant strains. 
 This study shows that E. coli isolates from urine 
were significantly more resistant than those from 
wounds that is burns and surgical sites. Isolates 
from non-surgical sites especially from urine, were 
slightly more resistant than those from surgical 
specimen (P: 0.0261). Similar high resistances among 
urine strains have been reported in related studies 
for instance, resistance rates among strains of E. coli 
isolated from women with urinary tract infection 
(UTI) averages 30% for both sulphonamides and 
ampicillin, varying from 17% to 54% in different 
countries (12). Trimethoprim resistance ranges from 
11% in Scandinavian countries to 34% in Spain and 
Portugal. Most Scandinavian countries record low 
resistance to fluoroquinolones but resistance to 
fluoroquinolones may reach 20% in southern Europe 
(12). 
 In Spain where antimicrobials can be used 
without restrictions, reduced susceptibility of 
E. coli strains isolated from patients with UTI 
to sulfamethoxazole-trimethoprim (SXT-TRIM) 
combinations has been reported to be as high as 26% 
and 16% to fluoroquinolones (13). 
 This current study shows that isolates obtained 
from urine were fairly susceptible to common 
agents used for the treatment of UTIs compared 
to those reported in other countries. These results 
differ from the expectation given the fact that the 
sample population was hospitalised patients who 
are generally reported to have isolates that are highly 
resistant (14).  Majority of isolates from urinary tracts 
were MDR and a significant proportion of these 
were resistant to sulfamethoxazole-trimethoprim 
(SXT-TRIM). These strains were also resistant to 
other classes of antimicrobials further limiting the 
choice of alternative antimicrobials. These results 
indicated similar sensitivity patterns amongst the 
uropathogens as those observed in Kolkata, India. 
The World Health Organization (WHO) guidelines 
recommend sulfamethoxazole-trimethoprim and 
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This study shows that E. coli  isolates from urine
were significantly more resistant than those from
wounds that is burns and surgical sites. Isolates
from non-surgical sites especially from urine, were
slightly more resistant than those from surgical
specimen (P: 0.0261). Similar high resistances among
urine strains have been reported in related studies
for instance, resistance rates among strains of E. coli 
isolated from women with urinary tract infection
(UTI) averages 30% for both sulphonamides and
ampicillin, varying from 17% to 54% in different
countries (12). Trimethoprim resistance ranges from
11% in Scandinavian countries to 34% in Spain and
Portugal. Most Scandinavian countries record low
resistance to fluoroquinolones but resistance to
fluoroquinolones may reach 20% in southern Europe
(12).
 In Spain where antimicrobials can be used
without restrictions, reduced susceptibility of
E. coli  strains isolated from patients with UTI
to sulfamethoxazole-trimethoprim (SXT-TRIM)
combinations has been reported to be as high as 26%
and 16% to fluoroquinolones (13).
 This current study shows that isolates obtained
from urine were fairly susceptible to common
agents used for the treatment of UTIs compared
to those reported in other countries. These results
differ from the expectation given the fact that the
sample population was hospitalised patients who
are generally reported to have isolates that are highly
resistant (14). Majority of isolates from urinary tracts
were MDR and a significant proportion of these
were resistant to sulfamethoxazole-trimethoprim
(SXT-TRIM). These strains were also resistant to
other classes of antimicrobials further limiting the
choice of alternative antimicrobials. These results
indicated similar sensitivity patterns amongst the
uropathogens as those observed in Kolkata, India.
The World Health Organization (WHO) guidelines
recommend sulfamethoxazole-trimethoprim and
ampicillin as the first choice for the UTI treatment
(15) and empiric treatment is recommended for
treatment of uncomplicated urinary tract infection
(uUTI) (16). However, as was revealed in the present
study, SXT-TRIM cannot serve as treatment of choice
among majority of these isolates.
 A recent report also indicated that SXT-TRIM
and ampicillin were not suitable drugs of choice for
treating UTIs (17). However, another study showed
that amikacin and nitrofurantoin are the most effective
treatments for UTIs in China (18). Since inappropriate
use of antibiotics may lead to complications and
treatment failure, this study suggest that there is a
need to have an idea of the resistance phenotypes of
isolates from urine before commencing treatment.
It is therefore important to conduct culture and
susceptibility testing for serious infections.
In conclusions, this study shows that isolates from
urine and wounds (bedsore, burns and surgical
wounds) are significantly resistant to common
antimicrobials available for use in Kenya. The E.
coli strains from urine are particularly resistant. A
few isolates are resistant to carbapenems indicating
that treatment of such strains would present a great
challenge in clinical settings. This study shows that
SMX-TRIM is no longer effective against most E. coli
isolates and that a significant proportion of these
strains are MDR. It has also been shown that women
may present a significant reservoir for MDR strains.
There is therefore need to check antimicrobial use
patterns in the management of burns and surgical
wound, UTIs and bedsore. There is also need to
promote culture and susceptibility testing for isolates
implicated in serious infections.
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